We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$73.4B
AUM Growth
+$1.61B
Cap. Flow
+$213M
Cap. Flow %
0.29%
Top 10 Hldgs %
34.33%
Holding
4,167
New
209
Increased
1,381
Reduced
1,653
Closed
198
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN icon
3451
Dyne Therapeutics
DYN
$4.68B
$5.5K ﹤0.01%
156
CWH icon
3452
Camping World
CWH
$384M
$5.46K ﹤0.01%
306
-2
-0.6% -$42
OCGN icon
3453
Ocugen
OCGN
$403M
$5.46K ﹤0.01%
+3,526
New +$5.49K
FUN icon
3454
Cedar Fair
FUN
$1.88B
$5.43K ﹤0.01%
100
CQQQ icon
3455
Invesco China Technology ETF
CQQQ
$3.01B
$5.43K ﹤0.01%
+162
New +$5.54K
VALU icon
3456
Value Line
VALU
$333M
$5.38K ﹤0.01%
125
STOK icon
3457
Stoke Therapeutics
STOK
$1.84B
$5.35K ﹤0.01%
+396
New +$5.35K
RXRX icon
3458
Recursion Pharmaceuticals
RXRX
$1.58B
$5.33K ﹤0.01%
710
+45
+7% +$392
DMRC icon
3459
Digimarc Corp
DMRC
$143M
$5.3K ﹤0.01%
171
+164
+2,343% +$4.17K
VMO icon
3460
Invesco Municipal Opportunity Trust
VMO
$651M
$5.3K ﹤0.01%
526
HCKT icon
3461
Hackett Group
HCKT
$281M
$5.3K ﹤0.01%
244
+113
+86% +$2.51K
VERV
3462
DELISTED
Verve Therapeutics
VERV
$5.3K ﹤0.01%
1,086
+760
+233% +$4.78K
EHAB
3463
DELISTED
Enhabit
EHAB
$5.3K ﹤0.01%
594
-136
-19% -$1.3K
STK
3464
Columbia Seligman Premium Technology Growth Fund
STK
$806M
$5.26K ﹤0.01%
+158
New +$5.03K
FLGB icon
3465
Franklin FTSE United Kingdom ETF
FLGB
$897M
$5.26K ﹤0.01%
200
AESI icon
3466
Atlas Energy Solutions
AESI
$1.27B
$5.26K ﹤0.01%
264
+160
+154% +$3.57K
PLUS icon
3467
ePlus
PLUS
$2.43B
$5.23K ﹤0.01%
71
-38
-35% -$2.9K
COLL icon
3468
Collegium Pharmaceutical
COLL
$1.18B
$5.22K ﹤0.01%
162
+4
+3% +$139
PROK icon
3469
ProKidney
PROK
$316M
$5.21K ﹤0.01%
+2,119
New +$5.69K
CHRS icon
3470
Coherus Oncology
CHRS
$217M
$5.19K ﹤0.01%
+3,001
New +$6.04K
IRMD icon
3471
iRadimed
IRMD
$1.2B
$5.19K ﹤0.01%
118
-40
-25% -$1.7K
BPT
3472
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$5.19K ﹤0.01%
2,100
-1,300
-38% -$3.14K
FATE icon
3473
Fate Therapeutics
FATE
$275M
$5.17K ﹤0.01%
+1,575
New +$6.89K
HYD icon
3474
VanEck High Yield Muni ETF
HYD
$4.44B
$5.17K ﹤0.01%
100
MQT
3475
DELISTED
BlackRock MuniYield Quality Fund II
MQT
$5.14K ﹤0.01%
500

Similar funds

US Bancorp's Q2 2024 Portfolio in Review

As of Q2 2024, US Bancorp held 4,167 positions worth $73.4B, up 2.2% from $71.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

US Bancorp's Q2 2024 filing shows 209 new, 1,381 increased, 1,653 reduced and 198 closed positions. Its largest new stake was Solventum: 547,442 shares worth $28.9M. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $1.24B.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • US Bancorp's largest Q2 2024 buy was Solventum: 547,442 shares worth $28.9M.
  • US Bancorp added most to Schwab US Large- Cap ETF in Q2 2024, an estimated $882M increase.
  • US Bancorp's biggest Q2 2024 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $1.24B.
  • US Bancorp fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $24M.
  • US Bancorp's ten largest holdings make up 34% of its $73.4B portfolio in Q2 2024.
  • US Bancorp opened 209 new positions and closed 198 in Q2 2024.
  • US Bancorp's portfolio value rose 2.2% quarter-over-quarter to $73.4B.

Based on US Bancorp's 13F filing for Q2 2024, filed 7 Aug 2024.